Today, the Union Budget was announced by Finance Minister Nirmala Sitharaman for the years 2023–2024. Let's find out what the budget has for ... Feb 01
Enzene Biosciences has raised $ 50 million to improve its manufacturing capability in order to provide affordable, high-quality medicines that save lives. ... Jan 31
... May 21
USA-based biosciences startup, TenSixteen jas raised $40 million in its Series A funding round from Foresite Capital and GV.... Jan 29
Latest news updates... Nov 12
Latest pharma news updates... Nov 02
Latest pharma news update... Sep 16
Latest pharma Update... Sep 06
Approval comes after Failure of at Least Two Lines of Prior Systemic Therapy... Feb 22
New drug for eosinophilic asthma on the way... Jan 16
Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the ... Jan 13
BYVASDA is an anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody and a bevacizumab biosimilar independently developed by Innovent Biologics... Dec 28
The agreement that gives Astrea the ability to secure exclusive access to the Affimer technology for applications in bioprocessing... Dec 22
... Dec 09
... Dec 05
MarzAA for the treatment of episodic bleeding in subjects with Hemophilia A or B with inhibitors ... Dec 04
Senhwa announces multiple IND application submissions to US FDA and Health Canada evaluating its investigational drug, CX-5461, for the treatment of patients with solid ... Nov 26
AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges... Nov 21
This collaboration will focus on the development of a novel class of hepatitis B virus (HBV) core protein modulators... Nov 18
Through this merger, the company will be able to deliver novel, multi-indication platform drugs designed to extend healthy lifespan and treat the source of ... Nov 13
Ligand’s Partner Sedor Pharmaceuticals receives US FDA approval for SESQUIENT for the treatment of status epilepticus in adult and paediatric patients ... Nov 07
This partnership also signifies Lesaffre's entry into the world of Synthetic Biology, considered to be the major biotechnological opportunity of this decade... Oct 31
CStone is a biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology and precision drugs ... Oct 30
This partnership puts LCB71 in a path to development and commercialization for patients around the world... Oct 29
-Advertisements-
Tuesday, December 05, 2023
